Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Adial Pharmaceuticals Inc | ADILW | NASDAQ | Equity Warrant |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0009 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0009 | 0.0009 |
| Trades | Volume | Avg Volume |
|---|---|---|
| 0 | 0 | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | 0.0009 | USD |
Adial Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.1k | 1.22M | - | 0 | -5.12M | -4.21 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Adial Pharmaceuticals
Adial Pharmaceuticals Signs Agreement with Boudicca Dx to Advance Regulatory Strategy for Companion Diagnostic Genetic Test for AD04 GlobeNewswire Inc. •
Tue Aug 13, 2024 9:00 AM (7 months ago)
Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder GlobeNewswire Inc. •
Wed Aug 07, 2024 9:00 AM (7 months ago)
Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044 GlobeNewswire Inc. •
Wed Jul 31, 2024 8:30 AM (7 months ago)
Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder GlobeNewswire Inc. •
Tue Jul 23, 2024 8:30 AM (7 months ago)
Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder GlobeNewswire Inc. •
Thu Jun 20, 2024 8:30 AM (9 months ago)
Adial Pharmaceuticals Achieves Important Milestone of First Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder GlobeNewswire Inc. •
Wed Jun 05, 2024 8:30 AM (9 months ago)
Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th GlobeNewswire Inc. •
Wed May 29, 2024 8:30 AM (9 months ago)
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update GlobeNewswire Inc. •
Wed May 15, 2024 8:30 AM (10 months ago)
Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office GlobeNewswire Inc. •
Mon Apr 22, 2024 8:30 AM (11 months ago)
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder GlobeNewswire Inc. •
Wed Apr 10, 2024 8:30 AM (11 months ago)
Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update GlobeNewswire Inc. •
Tue Apr 02, 2024 8:30 AM (11 months ago)
ADILW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. |
NASDAQ:ADILW -
What is the current Adial Pharmaceuticals Inc share price?
The current share price of Adial Pharmaceuticals Inc is $ 0.0009
How many Adial Pharmaceuticals Inc shares are in issue?
Adial Pharmaceuticals Inc has 1,218,000 shares in issue
What is the market cap of Adial Pharmaceuticals Inc?
The market capitalisation of Adial Pharmaceuticals Inc is USD 1.1k
What is the 1 year trading range for Adial Pharmaceuticals Inc share price?
Adial Pharmaceuticals Inc has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Adial Pharmaceuticals Inc?
The price to earnings ratio of Adial Pharmaceuticals Inc is -0.18
What is the reporting currency for Adial Pharmaceuticals Inc?
Adial Pharmaceuticals Inc reports financial results in USD
What is the latest annual profit for Adial Pharmaceuticals Inc?
The latest annual profit of Adial Pharmaceuticals Inc is USD -5.12M
What is the registered address of Adial Pharmaceuticals Inc?
The registered address for Adial Pharmaceuticals Inc is CORPORATION TRUST CENTER 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Adial Pharmaceuticals Inc website address?
The website address for Adial Pharmaceuticals Inc is www.adialpharma.com
Which industry sector does Adial Pharmaceuticals Inc operate in?
Adial Pharmaceuticals Inc operates in the PHARMACEUTICAL PREPARATIONS sector
